|Articles|September 16, 2020

Lockdowns: Should They Continue?

When lockdowns are done haphazardly, questions arise about whether they should continue.

The topic of lockdowns is one that has been ripe with debate since the SARS-CoV-2/COVID-19 pandemic began earlier this year. The debate has multiple facets and ultimately, the challenge most have seen is that if you’re going to do them, people need to support it and it needs to be for several weeks and on a large scale. Giving lockdowns the “ole college try” results in a frustrated population, limited efficacy, and ultimately more economic damage. Some countries have committed to a more effective approach, like Germany, while the United States struggled with roughly half a shutdown.

A new article though, seeks to address the lockdown in India, as public health officials from the Indian Public Health Association, the Indian Association of Epidemiologists, and the Indian Association of Social and Preventive Medicine, all joined for a joint statement to push the government to end the lockdowns. Moreover, this group emphasized that these restrictions should be replaced with widespread testing efforts.

In their call to action, the joint statement noted that the nationwide lockdown, which began in March, has been disjointed as it was relaxed but still upheld in several cities. Moreover, the country is focusing testing strategies on tracking and testing contacts of 80% of new COVID cases. Recently, this was 76,000 per day. This approach was widely criticized by public health leaders as both impractical, but also limited in its approach. With over 3.76 million cases recorded in India and nearly one million people currently under medical care for the disease, the seriousness of the outbreak in India is painfully obvious.

In their statement, the authors noted that the current testing strategy should focus more efforts on targeted testing. “They said that the current track and test policy had detected less than 5% of estimated infections, while antibody surveys had indicated a much larger epidemic. Delhi, for instance, with an estimated population of 20 million, has recorded 177 000 cases, but an unpublished survey by the Delhi government released last month found antibodies in 29% of the sampled population. A similar survey in Mumbai has recorded antibody prevalence as high as 58% in urban slums and 15% in non-slum localities.”

Moreover, with a government that is claiming a declining fatality rate as an indicator of an effective response, the public health officials emphasized that this drop from 3.3% to 2.7% over the course of two months, is really a product of more testing being done, allowing for earlier diagnosis and clinical management that is better poised at success. What’s most concerning is the focus on urban communities by the health ministry, while the authors note the increasing strain on the rural areas and the weakened health infrastructure that they rely on.

Overall, the authors emphasize that these haphazard, disjointed lockdowns are limited in their efficacy and efforts should be focused on enhancing testing capacity, as well as targeted approaches for high-risk populations. Like so many, this pandemic has stressed our approaches to public health emergencies, but now more than ever, it is important we listen to public health officials and weigh the efficacy of interventions and if they are truly being operationalized for success.


Related to this article

Ebola and the Ongoing Tale of US Failures
In mid-May, as the world was still grappling with an unexpected hantavirus outbreak aboard a tourism vessel, news broke of an Ebola outbreak in the Ituri Province of the Democratic Republic of the Congo spanning at least 3 health zones, including Bunia, Rwampara, and Mongbwalu.
This Week's Top 5 Infectious Disease News Stories: September 12-September 18, 2026
In this week's top infectious disease stories, a Pennsylvania teen became the state's fourth measles death in weeks, the CDC reported a 17% summer surge in rabies exposure calls, new research revisited whether cefepime raises mortality risk, a multihospital review examined ceftriaxone's safety after state alerts, and examining Legionella pneumonia diagnostics.
Measles Update: September 18, 2026
The latest CDC numbers show a 5.37% increase of measles cases from week-to-week. In Pennsylvania, the fourth measles-related death was reported in 2026. Additionally, the CDC has made a change in the way it will report deaths.
CDC Responds to Surge in Rabies Exposures
A "Clinician Outreach" from the Centers for Disease Control and Prevention (CDC) in April anticipated an increase in rabies exposures, and the striking surge in case reports this summer prompted a recent health advisory alert from the federal agency.
New Diagnositics for Legionella Pneumonia May Streamline Care Continuum
Reported cases of Legionnaires’ disease have been on the rise for the past decade, and identifying Legionella bacteria requires specialized testing in the microbiology lab. Here is a clinical overview of Legionella bacteria, including required testing, treatment, and reporting to public health officials.
Ceftriaxone Safety: Separating Signal From Risk
A retrospective multihospital study found that severe adverse events occurred at similarly low rates with ceftriaxone and other IV cephalosporins suggesting there is no evidence to support avoiding ceftriaxone despite recent health department safety alerts.